Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption by Pavlos, N. et al.
MOLECULAR AND CELLULAR BIOLOGY, June 2005, p. 5253–5269 Vol. 25, No. 12
0270-7306/05/$08.000 doi:10.1128/MCB.25.12.5253–5269.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Rab3D Regulates a Novel Vesicular Trafficking Pathway That Is
Required for Osteoclastic Bone Resorption†
Nathan J. Pavlos,1 Jiake Xu,1 Dietmar Riedel,3 Joyce S. G. Yeoh,1‡ Steven L. Teitelbaum,4
John M. Papadimitriou,2 Reinhard Jahn,3 F. Patrick Ross,4* and Ming H. Zheng1*
Units of Orthopaedics1 and Pathology,2 School of Surgery and Pathology, University of Western Australia,
QEII Medical Centre, Perth, Western Australia, Australia; Department of Neurobiology, Max Planck
Institute for Biophysical Chemistry, Go¨ttingen 37077, Germany3; and Department of Pathology,
Washington University School of Medicine, St. Louis, Missouri4
Received 6 December 2004/Returned for modification 10 February 2005/Accepted 4 March 2005
Rab3 proteins are a subfamily of GTPases, known to mediate membrane transport in eukaryotic cells and
play a role in exocytosis. Our data indicate that Rab3D is the major Rab3 species expressed in osteoclasts. To
investigate the role of Rab3D in osteoclast physiology we examined the skeletal architecture of Rab3D-deficient
mice and found an osteosclerotic phenotype. Although basal osteoclast number in null animals is normal the
total eroded surface is significantly reduced, suggesting that the resorptive defect is due to attenuated osteo-
clast activity. Consistent with this hypothesis, ultrastructural analysis reveals that Rab3D/ osteoclasts ex-
hibit irregular ruffled borders. Furthermore, while overexpression of wild-type, constitutively active, or pre-
nylation-deficient Rab3D has no significant effects, overexpression of GTP-binding-deficient Rab3D impairs
bone resorption in vitro. Finally, subcellular localization studies reveal that, unlike wild-type or constitutively
active Rab3D, which associate with a nonendosomal/lysosomal subset of post-trans-Golgi network (TGN) vesi-
cles, inactive Rab3D localizes to the TGN and inhibits biogenesis of Rab3D-bearing vesicles. Collectively, our
data suggest that Rab3D modulates a post-TGN trafficking step that is required for osteoclastic bone resorption.
Osteoclasts (OCs) are bone-resorbing polarized polykaryons
derived from cells of the myeloid lineage, (70) whose activity is
obligatory for skeletal maturation, tooth eruption and the
maintenance of calcium homeostasis (71, 74). Following at-
tachment to bone, OCs undergo plasmalemmal and cytoskel-
etal reorganization, resulting in formation of a highly enfolded
and specialized membrane domain, known as the ruffled bor-
der, that acts as the resorptive organelle of these cells. As a
consequence, both protons and a number of bone resorbing
enzymes, such as cathepsin K, type IV collagenase and other
matrix metalloproteinases (MMPs) are released into the un-
derlying resorption lacuna (68). In addition to its exocytic
properties, the ruffled border facilitates removal of degraded
bone matrix products via transcytosis (47, 48, 61, 69). Thus, like
other polarized cells, OCs require an intricate balance between
exocytic and endocytic vesicular trafficking to preserve ruffled
border membrane asymmetry and sustain their unique struc-
tural and functional segregation during bone resorption. At
present little is known about the molecular machinery that
regulates these transport pathways in OCs, although they are
predicted to share basic mechanism(s) with other vesicular
fusion systems conserved from yeast to neurons (46).
Current models of membrane fusion are dominated by con-
sideration of two types of proteins, namely small G proteins of
the Rab family and soluble N-ethylmaleimide-sensitive attach-
ment protein receptors (SNAREs) (31). Whereas SNAREs
and their interacting proteins play crucial roles in lipid bilayer
fusion, members of the Rab GTPase superfamily have emerged
as key regulators of vesicular budding, motility, tethering and
docking at all stages of exocytic and endocytic transport (57,
80). Over 60 Rabs exist in mammalian cells, each displaying
differential expression and subcellular localization (56). Like
other regulatory GTPases, Rabs act as molecular switches,
cycling between GTP-bound (activated) and GDP-bound (in-
active) conformations, enabling Rabs to recruit specific down-
stream effector protein complexes through which they elicit
their biological functions (80).
The Rab3 proteins (Rab3A, -B, -C, -D) are a highly homol-
ogous subfamily of Rabs thought to play important roles in
regulated exocytosis (32). Unlike most Rabs which are ubiqui-
tously expressed, the different Rab3 members are restricted to
cells types with high exocytic requirements (38, 45). Thus,
Rab3A and C are expressed predominantly in neurons and
neuroendocrine cells where they both localize to synaptic ves-
icles and secretory granules (22, 23). Rab3B is associated with
tight junctions and secretory granules in epithelial cells and
anterior pituitary glands (39, 78). In contrast, Rab3D is widely
expressed in nonneuronal cells including adipocytes, exocrine
glands and several haematopoietic cells, where it localizes to
secretory granules and vesicles (4, 50, 58, 76). Accumulated
evidence suggests that Rab3A and Rab3C act as negative reg-
ulators of exocytosis (25, 28), whereas Rab3B and Rab3D are
positive modulators of the same process (5, 15, 39, 53, 60).
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In the present study, we report the existence of Rab3D as
the major isoform in mouse OCs and their precursors. Disrup-
tion of Rab3D function by either targeted inactivation or over-
expression of a dominant-inhibitory Rab3D mutant impairs
osteoclastic bone resorption in vivo and in vitro, respectively.
Interestingly, this disruption correlates with morphological
disturbances in the ruffled border membrane. Localization
studies reveal that wild-type Rab3D associates with a subset
of post-trans-Golgi network (post-TGN) vesicles reminiscent
of secretory granules, while expression of dominant inhibitory
Rab3DN135I inhibits the biogenesis of these compartments.
Our data suggest that Rab3D is involved in regulating a pre-
viously uncharacterized post-TGN vesicle trafficking step that
contributes to the maintenance of the OC ruffled border mem-
brane and hence modulates the major function of the cell,
namely bone resorption.
MATERIALS AND METHODS
Antibodies and reagents. A primary rabbit polyclonal Living Colors A.v. Pep-
tide anti-enhanced green fluorescent protein (anti-EGFP) antibody was pur-
chased from Clontech Laboratories Inc, Palo Alto, CA. A rabbit polyclonal
anti-mouse Rab3A (K-15) antibody was purchased from Santa Cruz Biotechnol-
ogy Inc., Santa Cruz, CA. Rabbit polyclonal anti-mouse Rab3 (Cl42.1) antibody
was obtained from Synaptic Systems, Go¨ttingen, Germany. The generation and
characterization of polyclonal rabbit anti-Rab3D antibodies used in this study
have been described previously (58, 59). Rabbit polyclonal anti-rat TGN38 raised
against the C-terminal was kindly donated by George Banting (40). Alexa Fluor
546-conjugated goat anti-mouse immunoglobulin G (IgG), goat anti-rabbit IgG,
rhodamine-conjugated Phalloidin and Hoechst dye were all purchased from
Molecular Probes Inc., Eugene, OR. Triton X-114 was purchased from Sigma,
St. Louis, MO, while horseradish peroxidase (HRP)-conjugated goat anti-mouse
IgG and enhanced chemiluminescence (ECL) detection kits were purchased
from Amersham Life Science, Buckinghamshire, United Kingdom. RAW 264.7
murine macrophage/monocytes (clone C4) were kindly provided by Ian Cassady
(12). All tissue culture reagents were purchased from GIBCO-BRL, Life Tech-
nologies, Melbourne, Australia, unless stated otherwise.
Generation and isolation of mouse osteoclasts. OCs were generated in vitro
using one of two culture systems. First, RAW 264.7 cells were cultured in T-25
culture flasks at 105 cells/flask, in six-well plates at 2  104 to 2.5  104 cells/well,
in 96-well plates at 1 103 to 1.5 103 cells/well or on glass coverslips in 24-well
plates at 104 cells/well in minimal essential medium alpha modification (-
MEM) containing recombinant glutathione S-transferase (GST)–RANK ligand
(RANKL) (37, 79) at 50 to 100 ng/ml, with replacement of culture media every
2 to 3 days. OCs were evident after 5 to 7 days of culture. Cells were subsequently
harvested and processed for total RNA extraction, immunoblotting, or immu-
nocytochemistry. Alternatively, OCs were prepared from bone marrow macro-
phages (BMMs) by culture in -MEM–10% fetal bovine serum (FBS) at a
starting density of 1.5  105 cells per well in 48 well plates in the presence of 50
ng/ml human recombinant macrophage colony-stimulating factor (M-CSF; R&D
Systems, Minneapolis, MN). After 3 days, cells were cultured for a further 4 days
with GST-RANKL (100 ng/ml) and M-CSF (20 ng/ml). Cells were fixed and
stained for the OC marker tartrate-resistant acid phosphatase (TRAP). OCs
were scored as TRAPmultinucleated (more than three nuclei) cells. Cells were
subsequently harvested and processed for total RNA extraction, Western blot
analysis, or immunofluorescence confocal microscopy.
Mature primary OCs were mechanically disaggregated from the long bones of
1- to 3-day-old mice essentially as described in detail by the methods of Boyde et
al. (8) and Chambers et al. (13). Isolated cells were seeded onto either glass or
dentin surfaces for 24 h before being fixed and processed for immunohistochem-
istry.
Tartrate-resistant acid phosphatase staining and bone resorption pit assay.
Cells were stained for TRAP using a commercially available kit (387-A; Sigma),
according to published methods (37). After staining, cells were rinsed with
phosphate-buffered saline (PBS) and photographed and quantified under a light
microscope. To study the ability of OCs to form resorption pits on dentin, RAW
264.7 cells and BMMs were seeded onto 150-m-thick dentin slices and cultured
for 9 days in the presence of either GST-RANKL alone or in combination with
M-CSF. After 9 days, OCs were fixed and stained for TRAP activity. Dentin
slices were then incubated in 2 M NaOH (2 h) and cells were removed by
mechanical agitation and sonication. Resorption lacunae were visualized by
scanning electron microscopy (SEM) (82) and resorptive parameters quantitated
using Scion Image software (Scion Corporation, National Institutes of Health).
Reverse transcription (RT)-PCR cloning, Southern blotting, and sequence
analysis. Mouse OC and brain cDNAs served as templates for the identification
and isolation of Rab3 genes. Rab3 degenerative oligonucleotide primers were
designed based on the conserved sequences of Rab3/Ras consensus amino acid
sequences D1 (QNFDYM) and D2 (WDNAQV) (Genset Pacific Pty. Ltd.,
Lismore, Australia) (Table 1.). Total RNA was extracted from either mouse
bone marrow-derived OCs or snap frozen adult mouse brain (C57 black) with
RNAzol B (Tel Test, Friendswood, Texas) and mRNA was enriched using
DYNABEADS in accordance to the manufacturer’s instructions (DYNAL Inc.,
Lake Success, NY). cDNAs were synthesized from 2 g of purified mRNA using
100 U of Moloney murine leukemia virus (M-MLV) reverse transcriptase (Pro-
mega Corp., Madison, WI) as described by the manufacturer’s guidelines. PCR
was performed using 1.0 U DyNAzyme polymerase (GeneWorks, Hindmarsh,
Australia) with 0.4 mmol/liter of D1 and D2 primers, 125 mol/liter of dinucleo-
side triphosphate (dNTP) in 10 PCR buffer (GeneWorks) and water in a total
volume of 25 l. Amplification was performed in a DNA thermal cycler (model
2400; Perkin Elmer, Boston, MA), using 94°C for 5 min, 94°C for 30 s, 50°C for
2 min, 72°C for 30 s, and final extension at 72°C for 10 min. PCR products were
electrophoresed on a 1.5% agarose gel containing ethidium bromide (EtBr). A
342-bp amplimer corresponding to the predicted size of Rab3 proteins was gel
purified (GeneWorks) and subcloned into a pCR2.1 TA cloning vector (Invitro-
gen, Mt. Waverly, Australia). A total of 20 clones were sequenced in both
directions using an automated ABI 373 system and BLAST N (3) at the National
Center for Biotechnology Information (NCBI) was used to screen for DNA and
protein homologies via the world wide web.
For Southern blot analysis, agarose gels were depurinated in 0.25 M HCl for
10 min and subsequently transferred by capillary to a Hybond N membrane
(Amersham Life Science). Following transfer, membranes were washed and
hybridized for 16 h at 65°C with an -P32-labeled mouse Rab3 cDNA probe.
Stringency washes were carried out twice with 2 SSC (1 SSC is 0.15 M NaCl
plus 0.015 M sodium citrate), 0.1% sodium dodecyl sulfate (SDS) and once with
1 SSC, 0.1% SDS, and 0.2 SSC, 0.1% SDS. Finally membranes were exposed
to X-Omat Blue XB-1 X-ray film (Amersham Life Sciences).
Expression of mouse calcitonin receptor (CTR), Cathepsin K (Cath K), TRAP
and Rab3 isoforms in RAW 264.7 and RANKL-differentiated OCs was evaluated
by RT-PCR amplification using sets of gene specific primers based on published
TABLE 1. Degenerate and isoform-specific primers for mouse Rab3 cDNAsa
Region Sense primer Antisense primer
mRab3 deg. 5 CARAAYTTYGAYTAYATG 3 (D1) 5 NACYTGNGCRTTRTCCCA 3 (D2)
mRab3A 5 ATGGCTTCCGCCACAGACTC 3 5 TCAGCAGGCACAATCCTGAT 3
mRab3B 5 ATGGCTTCAGTGACTGAT 3 5 CTAACAAGAGCAGTTCTG 3
mRab3C 5 GGAATTCACAATGAGACACGAGGCG 3 5 GCTCTAGAGCTTAGCCAGCCACAGTTGGG 3
mRab3D 5 ATGGCATCCGCTAGTGAG 3 5 CTAACAGCTGCAGCTGCT 3
mTRAP 5 TGTGGCCATCTTTATGCT 3 5 GTCATTTCTTTGGGGCTT 3
mCTR 5 TGGTTGAGGTTGTGCCCA 3 5 CTCGTGGGTTTGCCTCATC 3
mCATH K 5 GGGAGAAAAACCTGAAGC 3 5 ATTCTGGGGACTCAGAGC 3
m36B4 5 TCATTGTGGGAGCAGACA 3 5 TCCTCCGACTCTTCCTTT 3
a Primer sequences were derived based on the published sequences deposited in GenBank.
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mouse sequences (Table 1.), using reverse transcription of total RNA isolated
with RNAzol B with 100 U of M-MLV reverse transcriptase (Promega). Two mi-
crolitres of each cDNA was subjected to PCR using 1.0 U of DyNAzyme poly-
merase (GeneWorks) with 0.4 mmol/liter of murine CTR, Cath K, TRAP, Rab3A,
Rab3B, Rab3C or Rab3D specific oligonucleotides (Genset Pacific Pty. Ltd), or 0.2
mmol/liter of acidic ribosomal phosphoprotein (36B4), 125 mol/liter of dNTP in
10 PCR buffer (Geneworks) and water in a total reaction volume of 25 l. Cycling
parameters (30 cycles) were 94°C for 5 min, 94°C for 30 s, and annealing (45 s)
of CTR at 62°C, of Cath K at 55°C, of TRAP at 55°C, of Rab3A at 62°C, of
Rab3B at 56°C, of Rab3C at 58°C, of Rab3D at 55°C, and of 36B4 at 55°C; 72°C
for 40 s; and a final extension step at 72°C for 10 min. Ten microliters of PCR
products were separated on a 1.5% agarose gel containing EtBr and photographed.
Protein isolation and immunoblotting. To isolate protein from cultured OCs
and RAW 264.7 cells, cells grown as monolayers were washed twice with ice-cold
PBS and then lysed in triple lysis buffer containing 50 mM Tris HCl (pH 8), 150
mM NaCl, 0.02% sodium azide, 0.1% SDS, 100 g/ml phenylmethylsulfonyl
fluoride (PMSF), 1 g/ml aprotinin, 1% Nonidet P40, 0.5% sodium deoxy-
cholate, and a mixture of protease inhibitors (Sigma) at 4°C for 30 min. For total
tissue protein extraction, snap-frozen tissues were ground mechanically by mor-
tar and pestle before being lysed for in triple lysis buffer. Both cell and tissue
lysates were cleared (12,000  g, 10 min) and resulting postnuclear supernatants
(PNS) were resolved by electrophoresis on a SDS–13% polyacrylamide gel and
blotted onto a nitrocellulose membrane (Hybond ECL; Amersham Life Sci-
ence), which was blocked in 5% skim milk in Tris-buffered saline–Tween 20
(TBS-T) for 40 min at room temperature. Enhanced yellow fluorescent protein
(EYFP)-tagged proteins were detected using a primary rabbit polyclonal Living
Colors A.v. Peptide antibody (anti-EGFP) (1:1,000) dilution (Clontech Labora-
tories Inc.) or primary rabbit polyclonal Rab3A (K-15) (1:300), Rab3D (1:5,000)
or Rab3 (Cl42.1) (1:10,000) antibodies by incubation for 2 h at room tempera-
ture. Membranes were washed and incubated with a secondary HRP-conjugated
anti-rabbit antibody (Sigma) at a 1:5,000 dilution for 1 h at room temperature.
Development was performed using an enhanced chemiluminescent detection kit.
Triton X-114 phase extraction. Triton X-114 extraction of PNS was carried out
as described by Bordier (1981) (7). Briefly, RAW 264.7 cell, OC and tissue PNS
were adjusted to 1% Triton X-114 and incubated at 4°C for 30 min, layered over
a sucrose cushion containing 6% sucrose, 10 mM Tris-HCl (pH 7.4), 150 mM NaCl,
and 0.06% Triton X-114, and incubated at 30°C for 5 min. Following centrifugation
(300  g for 3 min), the aqueous and detergent phases were collected and
adjusted to equal volumes. The detergent phases were subjected to SDS-PAGE
and immunoblotted for either EYFP or Rab3 isoforms as described above.
Protein concentration was estimated by Bradford assay (Bio-Rad; Hercules,
CA).
FISH. For in situ hybridization, PCR was used to generate a cDNA product
that encoded the entire open reading frame of murine Rab3D. Amplimers were
gel purified and cloned into the pCR2.1 vector using the Original TA Cloning Kit
(Invitrogen). All clones were sequenced for the confirmation of gene orientation.
Recombinant plasmids containing Rab3D inserts were linearized with BamHI
and transcribed into digoxigenin (DIG)-labeled antisense riboprobes with T7
RNA polymerase, using a DIG RNA labeling kit (Boehringer Mannheim, Mann-
heim, Germany). Fluorescence in situ hybridization (FISH) was performed on
OCs derived from neonatal mouse bone imprints, fixed with 4% paraformalde-
hyde in PBS, under high stringency conditions as described previously in detail
(29). Detection of hybridization signal was performed using a fluorescent anti-
body enhancer kit (Boehringer Mannheim). Signals were assessed by confocal
microscopy (Bio-Rad 1000; Bio-Rad).
Mice. Rab3D/ mice were generated as previously described (59). Littermate
controls were used for all experiments. Only female mice were used for quanti-
tative histomorphometric measurements. All animal work was approved by an
institutional ethics committee in compliance with the National Health and Med-
ical Research Council (Australia) guidelines.
Bone histology and histomorphometry. Twelve-week-old mice were used for
the assessment of bone phenotype. Tibiae and femora were excised, cleared of
soft tissue, fixed in 2% paraformaldehyde containing 0.5% glutaraldehyde in 0.1
M phosphate buffer overnight, and decalcified in 8% EDTA for at least 10 days.
Consecutive histological sections up to 20 slices per bone were stained with either
hematoxylin and eosin (H&E) or tartrate-resistant acid phosphotase histochem-
istry. Histomorphometric analysis of the secondary spongiosa was performed
according to standard methods (54). Statistical differences between groups were
assessed by Student’s t test.
Transmission electron microscopy. Transmission electron microscopy was car-
ried out essentially as described by the methods of McHugh et al. (44) but with
minor modifications. Briefly, long bones from 4- to 5-day-old Rab3D/ and
Rab3D/ littermates were dissected free of soft tissue and fixed with 2.5%
glutaraldehyde, 4% paraformaldehyde in 0.01 M cacodylate buffer (pH 7.3) for
at least 1 h at room temperature. After removal of the fixation solution, bones
were decalcified for 5 days in 14% EDTA (pH 7.4) containing 0.1% glutaralde-
hyde. Subsequently, bones were washed, postfixed with 1% osmium tetroxide,
dehydrated in ethanol, and embedded in Epon 812. Ultrathin sections were
counterstained with lead citrate and examined with a Phillips CM 120 Biotwin
transmission electron microscope (Phillips Inc, Eindhoven, The Netherlands).
Generation of stable RAW 264.7 cell lines expressing EYFP-Rab3D proteins.
An EYFP-Rab3D fusion protein construct was generated by excising a full length
Rab3D insert from a pBTM 116 expression vector with EcoRI and SalI and
sub-cloning the cDNA into the EcoRI and XhoI sites of the cytomegalovirus
(CMV) driven mammalian expression vector pcDNA 3.1 () (Invitrogen). An
approximately 700 bp region from the pEYFP vector was amplified using primers
() 5-ATGATTACGCCAAGCTTG-3 and () 5-CGGAATTCCTTGTACA
GC-3 to remove the TAA stop codon and insert a downstream EcoRI restriction
site. The amplified fragment was subcloned into a pCR2.1 TA cloning vector as
outlined in the manufacturer’s instructions (Invitrogen). The EYFP-EcoRI in-
sert was ligated into the BamHI and EcoRI sites of the pcDNA 3.1-Rab3D
containing expression vector. An EYFP expression vector was subsequently
generated by excising the EYFP-EcoRI cDNA insert from the pCR2.1 TA
cloning vector with BamHI and EcoRI and subcloning it into the pcDNA 3.1
mammalian expression vector. A myc-tagged mouse Rab3DQ81L vector, kindly
provided by Romano Regazzi (30), served as a template for the construction of
a Rab3DQ81L active mutant using a forward primer Q81L (5GGAATTCCG
GATGGCATCCGCTAGTGA-3) in combination with oligonucleotides corre-
sponding to the bovine growth hormone (BGH) polyadenylation sequence
present in the vector (5TAGAAGGCACACTCGAGG3). A Rab3DN135I mu-
tant was constructed by PCR using primers (GENSET Pacific PTY. Ltd) con-
taining a single nucleotide exchange leading to an amino acid exchange (N135I)
of the gene product. Forward primer (5-ATCCTCGTGGGGATTAAGTGTG
ACCTG-3) and reverse primer (5CAGGTCACACAC TTAATCCC CACGA
GGAT-3) were used. A Rab3DCXC mutant was established by deletion of the
last 3 amino acids (CSC) using a reverse primer 5-GCTCTAGAGCTAGCTG
CTCGGCTGTGG-3 paired with the EYFP forward primer. Wild-type Rab3D
fragments were excised from the pcDNA 3.1-EYFP vector and replaced by PCR
fragments containing the various mutations. All constructs were sequenced to
ensure fidelity of ligation and mutations.
To generate stable cell lines, expressing EYFP-Rab3D wild-type and mutant
RAW 264.7 cells were transiently transfected by electroporation essentially as
described previously (67) except that 20 g of plasmid DNA was used for the
transfection. After a 24-h recovery period, transfected cells were cultured in
selection media containing 500 g/ml geneticin (G418; Sigma) for 2 weeks.
Colonies resistant to the antibiotic were selected, expanded and expression levels
monitored using a combination of immunoblotting, FACS analysis, and confocal
microscopy. For fluorescence-activated cell sorting (FACS), the cells were
washed with PBS, trypsinized, pelleted, and resuspended in complete -MEM
(20% FBS) for sorting by a Facstar Plus cytometer (Becton Dickinson). Cell lines
were routinely resorted to maintain the homogeneity of the populations.
GTP-binding assay. Binding of [-P32]GTP to proteins blotted on nitrocellu-
lose membrane was carried out in accordance to the protocol of Bucci et al. (9).
Briefly, whole cell lysates were subject to SDS-PAGE and transferred to nitro-
cellulose membranes, which were incubated in binding buffer (50 mM sodium
phosphate, pH 7.5, 10 M MgCl2, 2 mM dithiothreitol [DTT], 0.2% Tween 20,
4 M ATP) for 30 min at room temperature, and then probed with 1 Ci/ml
[-P32]GTP (Amersham Life Sciences) in binding buffer for 2 h. After four 15
min washes with binding buffer, the blot was wrapped wet and exposed to film for
16 h and then subsequently stripped and processed for immunoblotting with
rabbit polyclonal anti-Rab3D antibodies.
Fluorescence and time-lapse confocal microscopy. RAW 264.7 cells and OCs
grown on glass coverslips were washed twice with PBS and fixed with 4% para-
formaldehyde in PBS, pH 7.2, for 15 min. Subsequently, cells were incubated for
5 min in 0.2% Triton X-100 in PBS. Following permeabilization, cells were
washed in PBS containing 2% bovine serum albumin (BSA) and labeled with
primary antibodies for 45 min at room temperature. After extensive washing with
PBS, primary antibodies were detected by goat anti-mouse, goat anti-rabbit, or
sheep anti-chicken immunoglobulin G conjugated to either Alexa Fluor 488 or
546 (Molecular Probes Inc.) at a dilution of 1:1,000. After 30 min of incubation,
cells were washed in PBS and mounted onto slides in low fade mounting medium
(25% glycerol, 15% polyvinyl alcohol in Tris-PO4, pH 8.5). For the detection of
F-actin microfilaments, cells were fixed and permeabilized as described above
and incubated with rhodamine-conjugated phalloidin (1:100; Molecular Probes
Inc.) for 2 h at room temperature. Cell nuclei were visualized by counterstaining
with Hoechst dye (1:10,000; Molecular Probes Inc.). In some experiments, cells
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were incubated at 37°C with rhodamine- dextran (10,000 molecular weight; 50
g/ml) for 4 h, Alexa Fluor 546-transferrin (20 g/ml) for 30 min, or the fixable
acidotropic probe Lysotracker Red DND-99 (100 nM) for 30 min (all from
Molecular Probes Inc.) before being fixed and processed for microscopy. Fluo-
rescence-based TRAP staining was performed according to the established
methods of Filgueira and outlined in detail in reference 21.
Detection of fluorochromes was carried out by confocal laser scanning micros-
copy (CLSM) (MRC-1000; Bio-Rad), equipped with a krypton-argon laser or
argon ion laser coupled to an epifluorescence Nikon Diaphot 300 inverted
microscope. For the detection of immunofluorescent staining and EYFP-signal,
both 60 oil immersion objective lens (Nikon; numerical aperture 	 1.6) and
40 UV oil immersion objective lens (Nikon; numerical aperture 	 1.2) were
used. Forty serial optical sections (z 	 0.1 m) were acquired satisfying the
Nyquist criteria for sampling. In some cases, individual OCs cultured on bone
slices were assessed throughout the entire cell using serial optical sections (1-m
intervals). The serial optical sections (z-series) from each cell were collected for
the construction of three-dimensional images.
For time-lapse microscopy, cells were grown on 8-well Coverglass chamber
slides (Nalge, Nunc International) in complete medium buffered with HEPES
(20 mM, pH 7.5) (Sigma H-3375) and mounted on a heated stage at 37°C. Serial
images were taken at 5-s intervals for 10 min, and stacks were played as AVI files.
Confocal sequences were collected as Bio-Rad PIC files and were converted to
bitmaps for use in either Scion Imaging software (NIH) or Confocal Assistant
4.02. Images were collected with nonsaturating conditions set up by the use of an
output look-up table (LUT).
RESULTS
Rab3D is the predominant Rab3 isoform expressed in
mouse osteoclasts. Following an earlier report (1) in which
only Rab3A and Rab3B/C isoforms were detected in OCs, we
employed a combination of complementary molecular, bio-
chemical, and cell biological approaches to examine expression
of Rab3 mRNA and protein expression in the same cells and
their mononuclear precursors. First, degenerative oligonucle-
otide primers based on conserved Rab3 family sequences (Fig.
FIG. 1. Expression of Rab3 isoforms in mouse osteoclasts. (A) Schematic representation of the RT-PCR strategy using degenerative Rab3
oligonucleotides coding for regions D1 and D2. Conserved structural domains between Rab and Ras proteins are designated G1-G5. ED denotes
effector-binding loop. The hatched region represents the membrane-binding motif (CXC). (B) Detection of Rab3 GTPases in BMM-derived OCs
by degenerative RT-PCR and Southern blot analysis. Sizes (in base pairs) were determined using DNA molecular weight (MW) standards. Brain
served as a positive control for Rab3 mRNA expression. Southern blotting was perform under high stringency conditions using an -P32-labeled
mouse Rab3 probe as outlined in the Materials and Methods. (C) mRNA expression and regulation of Rab3 isoforms in RANKL-differentiated
RAW 264.7 cells. RAW 264.7 cells were cultured in either the presence or absence of RANKL (100 ng/ml) for 0 to 5 days before being harvested
for mRNA extraction. cDNA was synthesized using 2 g of purified mRNA and then subjected to PCR amplification using gene specific primers
to mouse Rab3A, Rab3B, Rab3C, Rab3D, TRAP, Cath K, CTR and the internal control 36B4. (D) Immunodetection of Rab3 proteins in OCs
and bone. OC and tissue homogenates were extracted with Triton X-114 to enrich for Rab3 proteins that carry C-terminal geranylgeranyl
modification. Proteins (OC, 100 g; bone, 100 g) were analyzed by SDS-PAGE and immunoblotting with antibodies directed against Rab3A
(K-15), Rab3D and Rab3/A/B/C (42.1). Pancreas (50 g) and brain (10 g) serve as positive controls. (E) Cellular localization of Rab3D gene
transcripts in primary mouse OCs by FISH. Rab3D mRNA transcripts are evidenced by the green (FITC) hybridization signal. In situ hybridization
following RNase treatment show only background activity and served as a control. (F) Immunolocalization of Rab3D in nonpolarized and highly
polarized OCs. Isolated mature OCs were seeded onto either glass or dentin slices and cultured overnight before being fixed and immunostained
with primary polyclonal rabbit anti-Rab3D antibodies and secondary anti-rabbit antibody–Alexa 488 nm (green). Nuclei and filamentous actin were
visualized with Hoechst staining (blue) and rhodamine-labeled phalloidin (red), respectively. Bar, 10 m.
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1A; D1:QNFDYM 	 RabS1; D2:WDNAQV 	 RabS3) were
used to selectively amplify Rab3 cDNAs from bone marrow
monocyte-derived OCs. Brain cDNA was added as a positive
control because this organ is known to abundantly express
Rab3 proteins (24). As shown in Fig. 1B, a 342-bp fragment
corresponding to the predicted size for Rab3 GTPases was
amplified from both OC and brain cDNA. Southern blot anal-
ysis using a -P32-labeled mouse Rab3 probe confirmed the
identity of these products as Rab3 proteins. Cloning and se-
quence analysis revealed that the majority of clones (80%)
encoded mouse Rab3D, as documented by their identity with
the published sequence of mouse Rab3D (4). Similar results
were obtained using OCs obtained by RANKL-differentiated
RAW 264.7 cells. (Fig. 1C). Moreover, Rab3A and Rab3C
message is weakly expressed and confined to the early stages of
RANKL differentiation, while Rab3D expression is strong and
constitutive throughout osteoclastogenesis.
To confirm the PCR data, we next assessed Rab3 protein
expression levels in OCs by immunoblotting using a number of
well-characterized Rab3 specific antisera. When total protein
extracts were tested, we found that the endogenous expression
of Rab3 proteins was low and near the detection limit (unpub-
lished data). Geranylgeranylation (prenylation) is a posttrans-
lation lipid modification that is required for the binding of Rab
proteins to their target membrane(s) (66), thus rendering Rabs
hydrophobic and enabling them to be copurified with mem-
brane proteins by Triton X-114 partition (7, 20, 33). We used
these facts to circumvent the difficulty of detecting Rabs in
whole cell lysates, by enriching for geranylgeranylated Rab3
proteins with Triton-X-114, which selectively concentrates
membrane fractions. Figure 1D shows representative immuno-
blots of Rab3 proteins performed on Triton X-114 enriched
fractions of RAW 264.7 cell-derived OCs, bone, pancreas, and
brain. Brain and pancreas served as positive controls, as they
exhibit high levels of Rab3A/B/C and Rab3D, respectively (63,
76). In agreement with our PCR analyses and corresponding to
the published molecular weight, Rab3D is present in OCs as a
27-kDa peptide that comigrates with the pancreas control. The
FIG. 2. Osteopetrosis in Rab3D/ mice (A) Representative longitudinal sections of distal tibae from 12-week-old, sex-matched wild-type
(WT) and Rab3D/ mice stained with hematoxylin and eosin. More dense and irregular shaped trabecular bone was observed in the metaphyseal
region of Rab3D/ mice but not WT controls. (B) Histomorphometric analysis of tibial bone architecture. Trabecular bone volume (BV/TV),
trabecular number (Tb.N), trabecular separation (Tb.Sp), trabecular thickness (Tb.Th), and eroded surface (ES). Data are expressed as means 

SEM. (, P 0.025; , P 0.001). Results from five mice of each genotype are shown and were measured blindly. (C) Histologic sections of tibial
metaphysis of WT and Rab3D/ littermates stained for TRAP activity (red reaction product) to visualize OCs in vivo (200). (D) Normal ex vivo
OC formation in Rab3D/ mice. BMMs from either WT or Rab3D/ 6-week-old female mice were cultured for 7 days in the presence of M-CSF
(20 ng/ml) and RANKL (100 ng/ml) before being fixed and stained for TRAP. Note multinucleated cells derived form Rab3D/ BMMs are
indistinguishable from those derived from that of the WT. Bar, 10 m. (E) Quantitation of TRAP positive multinuclear cells (3 nuclei) following
a 7-day BMM/RANKL/M-CSF culture. Bars represent means 
 standard errors of the mean (n 	 6).
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same band is also evident in total bone extracts. In comparison,
immunoblotting using the polyclonal Rab3A antiserum failed
to detect significant levels of Rab3A expression in either OCs
or bone using equivalent amounts of protein, although it is
abundant in brain. While individual detection of Rab3B and
Rab3C isoforms is precluded due to the lack of appropriate
reagents, the monoclonal 42.1 Rab3 antibody, which recog-
nizes Rab3A/B/C, fails to detect significant levels of these
Rab3 proteins in OCs and bone but visualizes strong levels in
control brain lysates. We also find that the 42.1 antibody reacts
with Rab3D, albeit weakly, in highly expressing pancreatic
tissue (Fig. 1D). Interestingly, minimal Rab3 signal is detect-
able in aqueous/cytosolic fractions of OC protein extracts (un-
published data) indicating that endogenous Rab3 proteins are
membrane-affiliated in these cells.
Having established that Rab3D is the predominant Rab3
isoform expressed in OCs, we next confirmed its existence in
authentic mouse OCs. To this end, primary OCs were isolated
from the long bones of neonatal mice and probed for Rab3D
using fluorescence in situ hybridization (FISH) and immuno-
cytochemical methods. As shown in Fig. 1E, Rab3D mRNA is
present throughout the cytoplasm of mature OCs, which also
are positive for TRAP following double staining (unpublished
data). RNase treatment prior to hybridization resulted in loss
of signals in all cells, indicating the specificity of the probe for
its target mRNA sequence. Rab3D protein is also detected
throughout the cytosol in OCs when stained with Rab3D-
specific antisera in both nonresorbing and highly resorbing
OCs (Fig. 1F). Consistent with its membrane association,
Rab3D (green) is localized to small punctate structures rang-
ing in size from approximately 100 to 500 nm. These compart-
ments are randomly distributed throughout the cytosolic com-
partment but appear concentrated within the juxtanuclear/
Golgi region (nuclei in blue). Low levels of diffuse immuno-
fluorescence are also detected in the cytosol, probably reflect-
ing the unprenylated pool of Rab3D. Importantly, no appre-
ciable staining is observed in the absence of Rab3D antisera or
when OCs were treated with preimmune serum at equivalent
dilution. In actively resorbing cells, identified by characteristic
sealing zone formations (red), Rab3D-bearing vesicles show no
obvious sign of polarized targeting to either the ruffled border
or basolateral membrane domains. Thus, based on these data,
we conclude that Rab3D, rather than Rab3A/B/C, is major
Rab3 species expressed in mouse OCs.
Mice lacking Rab3D manifest a phenotype of osteopetrosis.
The abundance of Rab3D in OCs suggests that this GTPase
may play an important role in the physiology of these bone-
resorbing polykaryons. To test this hypothesis, we examined
the skeletal architecture of Rab3D-deficient mice. The animals
are viable and fertile and do not display any overt phenotypic
abnormalities (59). Histological examination of longitudinal
sections of the distal metaphyseal regions of tibias reveals a
higher trabecular bone volume in Rab3D/ mice compared
to wild-type (WT) littermates (Fig. 2A). In particular, the spa-
tial organization of the trabecular bone network is dense and
irregular within the metaphysis of Rab3D/ animals as com-
pared to their WT counterparts. Reflecting these morpholog-
ical aberrations, histomorphometric parameters of decalcified
tibial sections reveal that the volume of the trabecular bone
(BV/TV) in the Rab3D knockout (KO) mice is increased more
than two fold compared to WT mice (Fig. 2B). Consistent with
this finding, both trabecular number (Tb.N) and thickness
(Tb.Th) are increased by more than two-thirds in mice lacking
Rab3D. In addition, trabecular separation (Tb.Sp) and total
eroded surface (ES) are markedly lower in the bones of
Rab3D/ animals. In contrast, there is little detectable dif-
ference in cortical bone thickness and epiphyseal architecture
(unpublished data), suggesting no obvious effect of Rab3D on
bone formation by osteoblasts in vivo. Together these histo-
morphometric results indicate that mice lacking Rab3D are
osteosclerotic.
The decreased total eroded surface suggested that the bone
defect may reflect a deficiency in OC formation and/or activity.
To distinguish between these possibilities we stained bone sec-
tions for TRAP activity, an index of OC number in vivo. Visual
inspection reveals no obvious differences in OCs residing in the
bone metaphysis (Fig. 2C). To gain a more accurate assess-
ment of osteoclastogenesis, OC precursors, in the form of
BMMs, were cultured ex vivo for 7 days in the presence of
optimal concentrations of RANKL and M-CSF. As shown in
FIG. 3. (A) Disturbed ruffled border formation in OCs of Rab3D/
mice. Representative electron micrographs of OCs resident in metaph-
yseal bone of two individual WT and Rab3D/ mice. Note whereas
the ruffled borders of WT OCs exhibit characteristic villus-like projec-
tions, those of Rab3D/ are irregular and blunted. Bar, 1 m. (B)
Normal actin organization in Rab3D/ OCs. BMMs from WT and
Rab3D/ mice were cultured on glass coverslips for 7 days in the
presence of M-CSF (20 ng/ml) and RANKL (100 ng/ml). Multinucle-
ated cells were then fixed, permeablized, and stained with rhodamine-
phalloidin (red) to visual F-actin (red) and Hoechst to identify nuclei
(blue). Bar, 10 m.
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Fig. 2D, OCs from Rab3D/ animals form normally. Quan-
titative analysis reveals no significant difference in OC num-
bers either in vivo or during in vitro culture between Rab3D
KO and WT mice (Fig. 2E). We also failed to detect significant
differences in osteoblast bone nodule formation in vitro (un-
published data) which are consistent with the in vivo observa-
tions. Taken together, these data indicate that the osteoscle-
rotic phenotype is not related to changes in either OC or
osteoblast differentiation.
Since the ability of OCs to resorb bone is directly related to
their ability to form and sustain a functional ruffled membrane
we next used electron microscopy to examine the morphology
of the ruffled border in Rab3D null and WT cells for potential
anomalies (Fig. 3A). Strikingly, we find that the ruffled borders
of OCs derived from Rab3D mutant mice are structurally
abnormal. Whereas the ruffled borders of OCs from WT ani-
mals exhibit characteristic thin villous architecture, those in
Rab3D/ OCs consistently comprise thick, blunted projec-
tions, not unlike those present in 3 null OCs, which are also
dysfunctional (44).
FIG. 4. Expression and biochemical characterization of stably
expressed EYFP-Rab3D fusion chimeras in RAW 264.7 cells. (A)
Western blot analysis of lysates of RAW 264.7 cells transfected
with pEYFP and pEYFP-Rab3D, -Rab3DQ81L, -Rab3DN135I and
-Rab3DCXC. Stably transfected RAW 264.7 cells were lysed in stan-
dard sample buffer, and 50 g of total cell lysate was loaded for SDS-
PAGE and subsequently transferred onto a nitrocellulose membrane.
Incubation was performed using a polyclonal anti-Rab3D antibody,
and bands were visualized by the ECL detection system. The arrow-
head denotes endogenous Rab3D protein. (B) GTP-binding blot of
Rab3D WT and mutant proteins. Nitrocellulose membranes were
probed with either radiolabeled [-32P]GTP for 1 h or a polyclonal
anti-Rab3D antibody and subjected to autoradiography and chemillu-
minescent development. (C) Geranylgeranylation of EYFP-tagged
Rab3D fusions. RAW 264.7 cells expressing EYFP, EYFP-Rab3D, or
EYFP-Rab3D mutants were lysed in Triton X-114 to examine post-
translational processing. The lysates, normalized for protein content,
were warmed to 33°C, and the detergent (Dt) and aqueous (Aq)
phases were separated by centrifugation as described in Materials and
Methods. Equal proportions of each fraction were resolved by SDS-
PAGE and immunoblotting using an anti-EGFP (A.v. peptide) se-
rum. EYFP is hydrophilic and partitions almost exclusively into the
aqueous phase, whereas geranylgeranylation of the CXC motifs of
EYFP-Rab3D, EYFP-Rab3DQ81L, and EYFP-Rab3DN135I imparts
sufficient hydrophobicity to partition the proteins into the detergent
phase. Truncation of the CXC motif for EYFP-Rab3DCXC largely
results in partitioning to the aqueous phase. Prenylation is complete,
since all of the expressed EYFP-Rab3D and its GTP/GDP-mutants
shifted to the detergent phase. All results shown are representative of
at least three independent experiments.
FIG. 5. EYFP-expressing RAW 264.7 cells differentiate into func-
tionally authentic osteoclasts. (A) FACS analysis of postsorted stable
expressing EYFP-RAW 264.7 cells. (B through F) EYFP RAW 264.7
cells were stimulated with RANKL to induce differentiation. After 5
days, fully differentiated OCs were either examined by confocal mi-
croscopy to compare EYFP expression levels with their mononuclear
precursors (B and C) or stained with rhodamine-conjugated phalloidin
to visualize F-actin rings (D). (E) TRAP activity of EYFP-expressing
OCs. (F) Resorptive pits formed after 9 days of culture on dentin slices.
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The formation of the ruffled border coincides with reorgani-
sation of the cytoskeleton. Therefore, we asked if disruption of
the ruffled border reflects deficiencies in the OC actin cytoskel-
eton. To explore this possibility BMMs from wild-type and
Rab3D KO mice were cultured in the presence of M-CSF and
RANKL. After 7 days, OCs were fixed, permeabilized and
stained with rhodamine-phalloidin to visual filamentous actin.
As shown in Fig. 3B, OCs from Rab3D-deficient mice display
well-organized F-actin rings and podosomes that are compa-
rable to the analogous structures in WT cells, indicating that
the ruffled border deficiency is independent of actin cytoskel-
etal disturbances.
Disruption of osteoclastic bone resorption is dependent on
the guanine nucleotide binding, but not prenylation, status of
Rab3D. To gain further insight into the mechanisms by which
Rab3D regulates osteoclastic bone resorption, we used a mu-
tagenic approach to interfere with GDP/GTP cycling and
membrane targeting of Rab3D. Previous studies have shown
that substitution of glutamine (Q) at position 81 with leucine
(L) within the switch II GTP-binding domain of Rab3D results
in a protein that is deficient in GTP hydrolysis and persists in
the constitutively active GTP-bound conformation (15, 49, 63).
One the other hand, substitution of asparagine (N) at position
135 for an isoleucine (I) in the G4 motif leads to a constitu-
tively inactive protein that has reduced affinity for guanine
nucleotides and serves as a dominant-inhibitory mutant (5, 15,
41). Therefore, we constructed constitutively active and inac-
tive Rab3D mutants by site-directed PCR and stably expressed
them as enhanced yellow fluorescent protein (EYFP) fusions
in RAW 264.7 cells. In addition, we generated a geranylgera-
nylation mutant (EYFP-Rab3DCXC) by truncation of the
last three amino acids (CSC) of carboxyl terminal motif that is
required for membrane attachment and targeting (14). As a
control, a plasmid encoding EYFP alone was also expressed in
parallel.
Clones resistant to antibiotic selection were isolated and
expanded, and expression levels and transfection efficiencies
were assessed by immunoblotting and flow cytometry (Fig. 4
and unpublished data). As shown in Fig. 4A EYFP-fusion
chimeras were expressed at equivalent levels and moderately
overexpressed compared to the endogenous Rab3D protein.
To verify the biochemical characteristics of the fusion chime-
ras, we next evaluated their GTP-binding properties and gera-
nylgeranylation status. As expected, WT, constitutively active
and geranylgeranylation-deficient Rab3D fusion proteins effi-
ciently recruit GTP. On the other hand, GTP-binding affinity
is markedly enhanced in cells expressing constitutively ac-
tive EYFP-Rab3DQ81L, a result that confirms its reduced
GTPase activity (Fig. 4B). In comparison, no GTP-binding is
detectable for the guanine-nucleotide binding-deficient mutant
FIG. 6. Overexpression of dominant-negative Rab3DN135I impairs osteoclastic bone resorption in vitro. (A) RAW 264.7 cells stably expressing
EYFP-Rab3D and mutant proteins were cultured on dentin slices in the presence of RANKL (100 ng/ml) to analyze resorption activity. After 9
days, TRAP-positive cells were removed and resorptive lacunae were assessed by scanning electron microscopy. Whereas EYFP-Rab3D, consti-
tutively active EYFP-Rab3DQ81L and EYFP-Rab3DCXC expressing OCs produce numerous well-defined resorptive lacunae, those formed by
EYFP-Rab3DN135I OCs are shallow and poorly demarcated. (B) Resorption parameters of OCs expressing EYFP-Rab3D fusion proteins. Pit
number, diameter and percentage resorbed area per dentin slice were examined by scanning electron microscopy. Indices were calculated using
image analysis software (NIH). , P  0.05; , P  0.001 compared with EYFP in all panels; error bars represent standard deviation of means
(n 	 6).
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EYFP-Rab3N135I. Likewise, assessment of geranylgeranyla-
tion capacity by Triton X-114 phase partitioning revealed that
all EYFP-tagged Rab3D fusion proteins, with the predicted
exception of EYFP-Rab3DCXC, partitioned almost exclu-
sively into the detergent phase (Fig. 4C), indicating that they
are efficiently geranylgeranylated when expressed in RAW
264.7 cells.
We also determined whether expression of the EYFP-fusion
proteins is sustained during RANKL-induced OC differentia-
tion. As shown in Fig. 5, EYFP expression in RANKL-differ-
entiated OC-like cells is similar to that in its mononuclear
progenitors when compared at the same confocal laser set-
tings. Moreover, EYFP-expressing OCs are TRAP positive,
form characteristic F-actin rings, and are capable of resorbing
bone. Thus, based on these data, we conclude that stable ex-
pression of EYFP does not affect OC differentiation and func-
tion in vitro.
Having validated the use of EYFP-RAW 264.7 cell system,
we next examined the effects of the EYFP-Rab3D fusion chi-
meras on osteoclastic bone resorption. To this end, WT and
mutant EYFP-Rab3D stable RAW 264.7 cell lines were cul-
tured on dentin slices in the presence of RANKL. After 9 days
OCs were stained with TRAP and then removed to visualize
underlying resorption lacunae by SEM. As shown in Fig. 6A,
OCs overexpressing WT EYFP-Rab3D and constitutively ac-
tive EYFP-Rab3DQ81L resorbed bone with equal efficacy.
Expression of the prenylation-deficient mutant, EYFP-
Rab3DCXC, displayed similar resorptive ability and thus ap-
parently does not interfere with endogenous Rab3D activity.
These resorptive phenotypes are comparable to those of the
EYFP alone (Fig. 5) and untransfected OC controls (unpub-
lished data). In contrast, overexpression of dominant-negative
EYFP-Rab3DN135I impaired osteoclastic bone resorption.
Resorption pits of the N135I mutant are typically shallow with
poorly demarcated borders. Reflecting these resorptive defi-
ciencies, quantitative analysis reveals that both the number and
size of resorptive lacunae is markedly diminished in OCs ex-
pressing dominant-negative EYFP-Rab3DN135I compared to
all other transfected OCs (Fig. 6B). Furthermore, the percent-
age of total dentin surface resorbed is significantly lower in
OCs transfected with EYFP-Rab3DN135I as compared to
control cells. These differing resorptive capacities do not
reflect differences in osteoclastogenic abilities of individual
RAW 264.7 cell lines, because all stable EYFP-expressing
clones were derived from the same parental RAW 264.7 (C4)
sub-clone and subjected to equal rounds of passaging. Further-
more, we do not detect any significant differences in osteoclas-
togenic potential between the stable EYFP-expressing cell
lines (Fig. 7A and B), nor do we observe any differences in
their ability to activate osteoclastogenic signaling pathways
such as RANKL-induced ERK activation (unpublished data).
Consistent with our ex vivo observations, we also fail to observe
any quantitative morphology differences in the ability to form
F-actin rings, with more than 80% of all cells examined pos-
FIG. 7. Overexpression of EYFP-Rab3D and its mutants does not affect osteoclast formation or F-actin organization. (A) Stably transfected
RAW 264.7 cells were cultured on plastic or dentin surfaces in the presence of 100 ng/ml RANKL for 5 and 9 days, respectively. OC-like cells were
fixed and then stained for either TRAP alone (left panels) or double stained for TRAP and rhodamine-phalloidin (F-actin; middle and right
panels) and visualized by bright field and confocal microscopy. Quantitation of the number of TRAP-positive multinucleate cells (3 nuclei) per
cm2 (B) and number of F-actin rings per dentin slice (C). Error bars represent standard errors of the mean (n 	 6).
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sessing well-defined sealing zones (Fig. 7A and C). Together,
our findings indicate that formation of GTP-bound Rab3D,
rather than GTP hydrolysis or geranylgeranylation, is the rate-
limiting step regulating Rab3D function during osteoclastic
bone resorption.
GTP-Rab3D regulates the trafficking and biogenesis of a
subset of post-TGN vesicles. To further our analysis of the
intracellular events by which Rab3D regulates during bone
resorption, we next compared the subcellular distributions of
EYFP-tagged Rab3D WT and mutant proteins when ex-
pressed at equivalent levels in RAW 264.7 cells and OCs de-
rived therefrom (Fig. 8). In cells expressing WT EYFP-Rab3D
protein, the EYFP signal is enriched on small punctata that
resemble vesicles or granules, localizing in the immediate pe-
rinuclear region and often residing close to the plasma mem-
brane. In mononuclear RAW 264.7 precursors, these punctate
domains are particularly prominent at the cellular periphery
and within tips of processes that emanate from these cells. A
similar pattern of fluorescence is detected in cells expressing
constitutively active EYFP-Rab3DQ81L. However, this sub-
cellular localisation varies with the level of EYFP-Rab3DQ81L
overexpression. In weakly expressing cells, EYFP-Rab3DQ81L
localizes mainly in the perinuclear/Golgi region and on scat-
tered vesicles throughout the cytoplasm, whereas in cells ex-
hibiting strong expression levels of the active mutant, EYFP
signal is localized to large vesicular clusters/aggregates (some
1 m) in the cell periphery, but more concentrated in the
perinuclear region. In contrast, dominant negative EYFP-
Rab3DN135I associates with a juxta-nuclear Golgi-like struc-
ture(s) with lesser fluorescence diffusely detected throughout
the cytosol. Predictably, the EYFP-Rab3DCXC prenylation-
deficient mutant displays diffuse cytosolic fluorescence distri-
FIG. 8. Subcellular distribution of EYFP-Rab3D fusion proteins in RAW 264.7 cells and osteoclast-like cells. RAW 264.7 cells stably expressing
EYFP-Rab3D, EYFP-Rab3DQ81L, EYFP-Rab3DN135I and EYFP-Rab3DCXC were grown on either glass coverslips or dentin slices in either
the absence or the presence of RANKL (100 ng/ml) for 5 to 9 days. Cells were then fixed with 4% paraformaldehyde and processed for confocal
microscopy. Actively resorbing OCs were visualized by the presence of F-actin rings using rhodamine-conjugated phalloidin. Insets represent
magnifications of hatched regions. Each image is representative of a 0.4-m section.
5262 PAVLOS ET AL. MOL. CELL. BIOL.
 at M
AX PLANCK INST F BIO
PHY CHEM
 on M








bution that is comparable to that of EYFP alone. Similar
distribution is also observed in transfected COS-1 and PC12
cells (unpublished data), although the size of the Rab3D-pos-
tive vesicles varied slightly between the cell types.
While the above data provide information regarding local-
ization of Rab3D in fixed cells, they yield no insight into the
dynamic changes of Rab3 proteins. To address this issue we
performed time-lapse imaging of live cells. RAW 264.7 cells
stably expressing EYFP-Rab3D fusions were cultured on glass
chamber slides overnight before being transferred to a tem-
perature controlled stage (37°C) for confocal analysis. Stan-
dard imaging conditions used confocal microscopy to collect
single confocal slices every 5 s for periods up to 10 min. In this
circumstance, Rab3D-bearing vesicles shuttle in a randomized
fashion, displaying bidirectional short-range movements within a
limited area (less than 3 m in diameter in 10-min periods).
Occasionally we observe homotypic budding and fusion, indi-
cating that these are highly dynamic events (Fig. 9; see also
video S1 in the supplemental material). These results did not
arise because trafficking structures had moved out of the plane
of focus, i.e., “blink-out,” because individual homotypic fusions
can be continuously tracked for several minutes after vesicle
apposition has occurred. Similarly, numerous homotypic fusion
events between pleomorphic tubular-vesicular structures and
multivesicular aggregates are observed in RAW 264.7 cells
expressing the active EYFP-Rab3DQ81L mutant (see video S2
in the supplemental material). In most instances, larger aggre-
gates or clusters displayed limited directional motion and
tended to oscillate in live cells. By comparison, little vesicular
trafficking is observed in cells expressing EYFP-Rab3DN135I;
rather, EYFP signal appeared to be stably retained in the
paranuclear (Golgi) region (see video S3 in the supplemental
material).
To further dissect the nature of this Rab3D trafficking path-
way we performed immunostaining using a panel of well-char-
acterized Golgi, endosomal, and lysosomal compartment
markers. RAW 264.7 cells were used for the initial assessment
because of their well-characterized subcellular organization.
As shown in Fig. 10, WT and active Rab3D partially colocal-
ized with TGN38, a marker of the TGN. This colocalization is
accentuated in cells expressing the Golgi-restricted EYFP-
Rab3DN135I mutant. In contrast, little to no overlap is ob-
FIG. 9. Rab3D modulates the homotypic fusion of granules in living cells. RAW 264.7 cells expressing either EYFP-Rab3D WT or mutant
fusion proteins were cultured on Coverglass chamber slides for 24 h before being analyzed by time-lapse confocal microscopy on a heated stage
(37°C). Images were recorded at 5 s intervals for 10 min periods. Left panel illustrates merged phase contrast and EYFP images for each cell. Insets
represent enlarged selected images from a time-lapse series. Arrows denote EYFP-Rab3D-bearing vesicles/granules undergoing fusion events.
Note little dynamics is observed in EYFP-Rab3DN135I expressing cells (see videos S1 through S3 in the supplemental material).
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served with the early/recycling endosome marker transferrin
(Alexa fluor 546-tf, 30-min uptake), the fluid phase endosomal
marker dextran (Rh-dextran, 10,000 molecular weight, 4-h up-
take), and the lysosome-specific vital dye LysoTracker, indicat-
ing that Rab3D is not associated with late endosomal and/or
lysosomal compartments. Similar localization patterns are ob-
served in RAW 264.7 cell-derived OCs (Fig. 11 and unpub-
lished data).
Finally, to investigate whether Rab3D-bearing vesicles are
associated with other established osteoclast-specific markers,
we examined the intracellular localization Rab3D in relation to
TRAP, a known secreted enzyme which has been shown to
localize to transcytotic vesicles (26, 75). As shown in Fig. 12,
little to no overlap is observed between large TRAP-positive
vesicles and Rab3D, suggesting that Rab3D regulates a vesicle
transport pathway that is morphologically and functionally di-
vergent from the intracellular trafficking of TRAP.
DISCUSSION
In the past few years, several lines of evidence hint that Rab
GTPases play crucial roles in regulating OC function. Disrup-
tion of Rab geranylgeranylation by NE10790 (a bisphospho-
nate analogue specific to Rab geranylgeranyl transferase) di-
rectly inhibits osteoclastic bone resorption, an outcome that
correlates with morphological disturbances in vesicle traffick-
ing (17). Antisense oligonucleotide depletion of Rab7, an en-
dosomal/lysosomal related GTPase, impairs osteoclastic po-
larisation and bone resorption in vitro (81). While it has also
been suggested that the Rab3 subfamily plays a role in ruffled
border plasmalemma expansion (1), this hypothesis has not
been directly tested. In the present study, we document for the
first time the existence of a Rab3D-mediated vesicle transport
pathway that is required for bone resorption. Attesting to the
importance of this trafficking step, disruption of Rab3D activity
by either targeted inactivation or expression of dominant-neg-
FIG. 10. Rab3D is associated with a nonendosomal/lysosomal post-TGN vesicular compartment. Stably transfected RAW 264.7 cells expressing
EYFP-Rab3D fusions were labeled with organelle-specific markers. To visualize the TGN, cells were incubated with anti-TGN38 and Alexa Fluor
546–goat anti-rabbit secondary antibodies. For early and recycling endosomes, cells were loaded with either Alexa Fluor 546-transferrin (30 min)
or the fluid phase marker -rhodamine-dextran (10,000 molecular weight) (4 h) prior to fixation. Acidic compartments were identified with
LysoTracker Red. Whereas EYFP-Rab3D partially colabeled with the TGN (yellow), very little overlap can be observed with other endocytic
compartment markers.
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ative Rab3DN135I leads to significant impairments in oste-
oclastic bone resorption in vitro and in vivo. Moreover, OCs
lacking Rab3D manifest abnormal ruffled borders. Finally, our
studies reveal that in OCs, Rab3D associates with and regulate
the biogenesis of a subset of post-TGN vesicles that are rem-
iniscent of secretory granules. Together, our data add Rab3D
to the list of small GTPases known to regulates OC activity
(18) and suggest that this molecule modulates a previously
uncharacterized post-TGN trafficking step that contributes to
the maintenance of the ruffled border membrane.
Previous studies employing immunoblotting have reported
the existence of at least two Rab3 isoforms (Rab3A, Rab3B/C)
in murine osteoclastic cells (1). In the present study, using an
equivalent culture system, we identified all four Rab3 GTPases
by degenerative RT-PCR. Moreover, using a combination of
molecular, biochemical, and cell biological methods, we dem-
onstrate that Rab3D, rather than Rab3A/B/C, is in fact the
major Rab3 species expressed in mature OCs. The discrepancy
between our data and those of Abu-Amer et al. probably
results from differences in both culture systems and methods of
detection. Thus, the variations in expression profiles might
reflect the presence of contaminating bone cell species such as
osteoblasts and chondrocytes which have been recently re-
ported to express Rab3A, -B, and -C (6, 55). Furthermore, the
42.1 antibody used in studies of Abu-Amer et al. lacks the
specificity to discriminate between Rab3A/B/C/D isoform. In
contrast, we used an antibody that uniquely recognizes Rab3D.
The functions of many Rab proteins have been classically
dissected by either genetic inactivation in mice and nematodes
or the use of interfering mutants (2, 9, 25, 51, 64). Rab3D/
mice have been recently shown to have enlarged secretory
granules in pancreatic acinar cells (59). Our finding that
Rab3D/ mice exhibit an osteosclerotic phenotype extends
the physiological importance of GTPases to bone remodeling.
The fact that Rab3D/ mice undergo normal development
and yet have a cumulative resorptive defect in vivo indicates
that Rab3D is not important during development, but rather
plays a role during adult life. This conclusion mimics the com-
FIG. 11. Colocalization of Rab3D with the TGN in osteoclasts. Stably transfected RAW.264.7 cells overexpressing either EYFP-Rab3D or its
mutants were cultured on glass coverslips in the presence of RANKL (100 ng/ml). After 5 days, cells were fixed with 4% paraformaldehyde,
permeabilized, and labeled with a rabbit polyclonal rat anti-TGN38 (primary) antibody and Alexa Fluor 546-congated goat anti-rabbit (secondary)
antibodies as described in Materials and Methods. Cells were then mounted in low fade mounting medium and analyzed by confocal micros-
copy. Colocalization depicted by yellow color in merged images. Insets represent magnification of hatched regions.
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plex bone phenotypes of mice lacking the 3-integrin, DAP12,
Wasp, or NIK, each of which exhibits progressive osteosclero-
sis (11, 35, 44, 52). In the case of 3, disruptions in OC activity
are mirrored by deficiencies in ruffled border formation. Con-
sistent with these earlier observations, ultrastructural analyses
in the present study reveals that OCs lacking Rab3D possess
similarly disorganized ruffled borders, suggesting that Rab3D
may be an important modulator of the ruffled border forma-
tion and hence OC function.
Our in vitro mutagenesis studies provide further support for
the concept that Rab3D plays a substantial role in bone re-
sorption. Whereas overexpression of WT, constitutively active
and prenylation deficient mutants of Rab3D do not exhibit any
significant abnormalities, expression of the dominant-negative
Rab3DN135I results in a profound impairment of osteoclastic
bone resorption. These results are similar to those employing
analogous Rab3D mutants in AtT20 cells, mast cells and pan-
creatic acini (5, 15, 19, 60). It may seem surprising that the
FIG. 12. Intracellular localization of Rab3D and TRAP in osteoclasts. RAW 264.7 cell-derived OCs cultured on glass coverslips were fixed with
4% paraformaldehyde before being stained for TRAP activity (magenta) using a fluorescence-based protocol (see Materials and Methods). OCs
were subsequently double immunostained for Rab3D (green), and rhodamine-phalloidin (F-actin, red) before being stained with Hoechst to
visualize cell nuclei (blue). Each panel shows a projection image of scanned x-y sections through the cell. Merge represents an overlap of all four
color channels. Inset represents magnification of hatched region. White color indicates colocalization. Bar, 10 m.
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resorptive deficiency in OCs harboring the N135I mutation is
greater than to those from Rab3D KO animals. Thus far there
has been no simple explanation for this discrepancy; however,
it may reflect the differences in the systems employed (loss-of-
function mutation verses gene ablation). In the case of Ras,
it is now well established that, due to their reduced nucleo-
tide-binding and thus higher tendency to attain a guanosine-
nucleotide free state, dominant-inhibitory N-I mutants work
by competing with normal endogenous Ras for binding to Ras-
activation factors, i.e., Ras GEFs (27, 65, 77). This high affinity
results in the formation of “dead-end” complexes, thereby
preventing the activation of endogenous Ras by Ras GEF
resulting in loss of function. The dominant-negative Rab mu-
tants are thought to function similarly (10, 34, 43). Indeed,
recent studies have shown that disruptions in pancreatic secre-
tion are largely attributable to dominant-negative Rab3D mu-
tants’ ability to inhibit endogenous Rab3D activation, presum-
ably via sequestering Rab3 GEFs (15, 16). Thus, considering
the high homology of Rab3 isoforms, it is likely that seques-
tering Rab3 GEFs by Rab3DN135I not only disrupts endog-
enous Rab3D GDP/GTP exchange in OCs but inhibits the
activation of other endogenous Rab3 proteins or Rab3-like
molecules that may contribute to the resorptive process and
thus account for the more pronounced resorptive defect. On
the other hand, a single gene deletion in Rab3D-deficent
might be compensated, at least partially, by redundancy. This is
perhaps best exemplified by the recent phenotypic assessment
of Rab3 quadruple KO mice which found that while the ab-
sence of all four Rab3 isoforms is lethal at birth, the expression
of a single Rab3 allele is sufficient for survival (64).
Another interesting finding is the normal F-actin organiza-
tion in Rab3D-deficent and mutant OCs, in light of the drastic
impairments in ruffled border formation and bone resorption
in vitro and in vivo. We interpret this observation to mean that
a post-TGN vesicle trafficking step regulated by Rab3D is
uncoupled from the cytoskeletal reorganization that accompa-
nies OC attachment and formation of the sealing zone. This
hypothesis is supported by two independent studies. First, the
recent finding that while GGTOH treatment disrupts Rab ac-
tivity and inhibits bone resorption in vitro, OCs still maintain
their ability to form actin rings, implying that they are not
coupled events (17). Second, studies by Saltel et al. (62) re-
ported that OCs retained normal sealing zones following the
blockade of Golgi trafficking.
An important step in unravelling the function of a mem-
brane trafficking protein is to define its subcellular localization.
Previous localization studies indicate that Rab3D is an estab-
lished marker of secretory vesicles and granules. For example,
Rab3D associates with zymogen granules in the exocrine pan-
creas (76), dense-core secretory granules in PC12 (41, 42) and
AtT-20 cells (5), and -hexosaminidase-containing granules in
mast cells (19, 60, 73). In the present study, we find that Rab3D
associates with a unique subpopulation of post-TGN vesicles
in OCs and their monocytic precursors. This conclusion is
founded on several morphological observations. First, the co-
localization between Rab3D and markers of the TGN is con-
sistent with it being a late exocytic carrier vesicle. Second,
Rab3D-bearing vesicles, although superficially comparable to
endosomes and lysosomes, do not associate with a number of
established early or late endocytic/lysosomal markers. Third,
Rab3D-bearing vesicles are morphologically distinct from
TRAP-containing transcytotic compartments (26, 75). Fi-
nally, time-lapse confocal microscopy reveals that Rab3D-
bearing vesicles bud dynamically from the TGN and undergo
homotypic fusions, an event analogous to immature granule-
granule fusions as occur during secretory granule maturation
(72). It appears that Rab3D functions as a molecular on/off
switch to regulate the biogenesis and/or maturation of these
compartments, as such events are blunted by inhibition of
Rab3D activity. These findings are consistent with the hypoth-
esis that Rab3D regulates the maintenance and maturation of
secretory granules (59). Additional support for this position is
provided by recent findings that show expression of dominant-
inhibitory mutants of Rab3D impairs the biogenesis of secre-
tory granules in neuroendocrine and endothelial cells (5, 36,
41).
In summary, our results raise the intriguing possibility that
Rab3D functions to regulate a previously undocumented,
physiologically relevant, rate-limiting post-TGN trafficking
step that is required for the maintenance of the ruffled border
during osteoclastic bone resorption. Future characterization of
the content(s) and nature of these compartments together with
the identification of the complement of effector molecules
through which Rab3D exerts its regulatory function may un-
cover potential novel antiresorptive targets for the treatment
of OC-mediated bone diseases.
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